Patrick K Reville, MD, MPH¹, Hagop Kantarjian, MD², Gautam Borthakur, MD², Naveen Pemmaraju, MD², Courtney D. DiNardo, MD, MSCE², Koji Sasaki, MD³, Naval Daver, MD⁴, Ghayas C. Issa, MD², Maro Ohanian, DO^2*, Guillermo Montalban-Bravo, MD², Nicholas Short, MD⁵, Nitin Jain, MD³, Kapil N. Bhalla, MD², Elias Joseph Jabbour, MD⁶, Alessandra Ferrajoli, MD², Koichi Takahashi, MD, PhD², Caitlin R. Rausch, PharmD^7*, Rashmi Malla, RN, BSN^2*, Kelly Marek^2*, Mark Brandt, BS^2*, Uday R. Popat, MD⁸, Michael Andreeff, MD, PhD², Guillermo Garcia-Manero, MD², Marina Konopleva, MD, PhD², Farhad Ravandi, MB Bs⁹ and Tapan M. Kadia, MD¹⁰

¹Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁴MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, HOUSTON, TX
⁶Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
⁷Department of Pharmacy, University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
¹⁰Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX

Chong Chyn Chua, MBBS, FRACP, FRCPA^1,2,3, John Reynolds, PhD^2,4*, Anoop Kumar Enjeti, MBBS, FRCPA, FRACP, PhD, MD, MRCP^2,5, Devendra Hiwase, MBBS, MD, FRACP, FRCPA, PhD^2,6, Paula Marlton^2,7, Ashish Bajel, MBBS, FRACP, FRCPA^2,8,9, Shuh Ying Tan, MBBS^2,10*, Edward S. Morris, BMBS, DM^2,11, Chun-Kei-Kris Ma, BSc(Med), MBBS, PhD, FRACP, FRCPA^2,12*, Carolyn Grove, MBBS, PhD^2,13*, Julian Cooney, MBBS, FRACP, FRCPA^2,14, Ashanka Beligaswatte, MBBS, FRACP, FRCPA^2,15*, Natasha Anstee, PhD^3,16*, Stephen B Ting, MBBS, FRACP, FRCPA, PhD^2,17*, Travis Perera, MB ChB, FRACP, FRCPA^2,18*, Amanda Johnston, MBBS, FRACP, FRCPA^2,19, David Ritchie, MB ChB, PhD, FRACP, FRCPA^2,9,20 and Andrew H. Wei, MBBS, PhD^2,3,16

¹The Alfred Hospital & Monash University, Melbourne, VIC, Australia
²Australasian Leukaemia and Lymphoma Group (ALLG), Melbourne, VIC, Australia
³Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia
⁴The Alfred and Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia
⁵Department of Haematology, Calvary Mater Newcastle Hospital, Sydney, NSW, Australia
⁶Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia
⁷Princess Alexandra Hospital and University of Queensland, Brisbane, Australia
⁸Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia
⁹Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia
¹⁰Department of Haematology, St Vincent’s Hospital, Melbourne, VIC, Australia
¹¹Townsville Cancer Centre, Townsville, QLD, Australia
¹²Department of Haematology, Westmead Hospital, Sydney, NSW, Australia
¹³Department of Haematology, PathWest & Sir Charles Gairdner Hospital, Department of Health, Nedlands, WA, Australia
¹⁴Department of Haematology, Fiona Stanley Hospital, Perth, WA, Australia
¹⁵Department of Haematology, Flinders Medical Centre, Adelaide, Australia
¹⁶Department of Haematology, The Alfred Hospital, Melbourne, VIC, Australia
¹⁷Department of Haematology, Box Hill Hospital and Monash University Eastern Health Clinical School, Melbourne, VIC, Australia
¹⁸Wellington Blood and Cancer Centre, Wellington, New Zealand
¹⁹Westmead Hospital, Westmead, NSW, Australia
²⁰Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia

Gail J. Roboz, MD¹, Thomas Pabst, MD², Ahmed Aribi, MD³, Joseph M. Brandwein, MD^4*, Hartmut Döhner, MD⁵, Walter Fiedler, MD⁶, Domenica Gandini, MD, PHD^7*, Michelle Geddes, MD, FRCPC^8*, Jing-Zhou Hou, MD, PhD⁹, Angela J. Howes, BSc, PhD¹⁰, Anna Hultberg, PhD^7*, Eric Huselton, MD¹¹, Julie Jacobs, PhD^12*, Colleen Kane, PhD, VMD¹³, Ewa Lech-Marańda, MD, PhD^14*, Marieke Louwers, PhD^7*, Kerri Nottage, MD, MPH^15*, Uwe Platzbecker, MD¹⁶, Raajit Rampal, MD, PhD¹⁷, Mariya Salman, PhD^15*, Priya Shah, MBBS^18*, Don Stevens, MD¹⁹, Monic Stuart, MD, MPH^7*, Marion Subklewe, MD²⁰, Anne Sumbul, MSc^7*, Eunice S. Wang, MD²¹, Agnieszka Wierzbowska, MD, PhD^22*, Bin Yao^7*, Karen Yee, MD²³, Hagop Kantarjian, MD²⁴ and Gautam Borthakur, MD²⁵

¹Division of Hematology Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
²Department of Medical Oncology, University Hospital, Bern, Switzerland
³City of Hope National Medical Center, Duarte, CA
⁴University of Alberta, Edmonton, Canada
⁵Department of Internal Medicine III, Bone Marrow Transplantation Unit, University Hospital of Ulm, Ulm, Germany
⁶Universitätsklinik Hamburg-Eppendorf, Hamburg, Germany
⁷argenx, Ghent, Belgium
⁸Tom Baker Cancer Centre, Calgary, Canada
⁹University of Pittsburgh School of Medicine, Pittsburgh, PA
¹⁰Janssen R&D, High Wycombe, PA, United Kingdom
¹¹University of Rochester, Rochester, NY
¹²argenx, Ghent, MA, Belgium
¹³Janssen R&D, Spring House, PA
¹⁴Instytut Hematologii i Transfuzjologii Indiry Gandhi 14, Warsaw, Poland
¹⁵Janssen R&D, Raritan, NJ
¹⁶Universitätsklinikum Leipzig, Leipzig, Germany
¹⁷Memorial Sloan Kettering Cancer Center, New York, NY
¹⁸Janssen R&D, High Wycombe, ENG, United Kingdom
¹⁹Norton Healthcare, Norton Cancer Institute, Louisville, KY
²⁰Klinikum der Universität München, Munich, Germany
²¹Roswell Park Comprehensive Cancer Center, BUFFALO, NY
²²Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im., Lodz, Poland
²³Princess Margaret Cancer Centre, Toronto, ON, Canada
²⁴University of Texas MD Anderson Cancer Center, Houston, TX
²⁵MD Anderson Cancer Center, The University of Texas, Houston, TX

Musa Yilmaz, MD¹, Muharrem Muftuoglu, MD², Hagop Kantarjian, MD³, Courtney D. DiNardo, MD, MSCE³, Tapan M. Kadia, MD³, Marina Konopleva, MD, PhD³, Gautam Borthakur, MD⁴, Naveen Pemmaraju, MD³, Nicholas Short, MD⁵, Yesid Alvarado, MD³, Abhishek Maiti, MBBS^3*, Lucia Masarova, MD^6*, Guillermo Montalban-Bravo, MD³, Carissa Jurisprudencia^7*, Allison M. Pike, RN^8*, Sanam Loghavi, MD⁹, Keyur Patel, MD, PhD^10*, Guilin Tang, MD, PhD^10*, Jairo A. Matthews^4*, Steven Kornblau, MD⁴, Elias Joseph Jabbour, MD¹¹, Guillermo Garcia-Manero, MD¹², Vivian Ruvolo, MS^2*, Farhad Ravandi, MB Bs³, Michael Andreeff, MD, PhD³ and Naval Daver, MD³

¹Department of Leukemia, MD Anderson Cancer Center, Houston, TX
²Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, HOUSTON, TX
⁶University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX
⁷MD Anderson Cancer Center, Houston, TX
⁸The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX
⁹Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
¹⁰Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
¹²The University of Texas MD Anderson Cancer Center, Houston, TX

Naval Daver, MD¹, Marina Konopleva, MD, PhD², Abhishek Maiti, MBBS^2*, Tapan M. Kadia, MD³, Courtney D. DiNardo, MD, MSCE², Sanam Loghavi, MD⁴, Naveen Pemmaraju, MD², Elias Joseph Jabbour, MD⁵, Guillermo Montalban-Bravo, MD^2*, Guilin Tang, MD, PhD^6*, Koji Sasaki, MD⁷, Gautam Borthakur, MD⁸, Musa Yilmaz, MD⁹, Joie Alvarez, BSN^2*, Michelle Golez^10*, Sherry A. Pierce, BSN, BA^2*, Graciela M. Nogueras González, MPH^11*, Jing Ning^12*, Hussein A Abbas, MD, PhD¹³, Farhad Ravandi, MB Bs¹⁴, Guillermo Garcia-Manero, MD² and Hagop Kantarjian, MD²

¹MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
⁴Department of Hematopathology, MD Anderson, Houston, TX
⁵Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
⁶Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁸MD Anderson Cancer Center, The University of Texas, Houston, TX
⁹Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
¹⁰The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
¹²department of biostatics, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
¹³Division of Cancer Medicine, Medical Oncology Fellowship, UT M. D. Anderson Cancer Center, Houston, TX
¹⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, HOUSTON, TX

Naval Daver, MD¹, Ahmed Aribi, MD², Pau Montesinos, PhD, MD^3*, Gail J. Roboz, MD⁴, Eunice S. Wang, MD⁵, Roland B. Walter, MD, PhD, MS⁶, Deepa Jeyakumar, MD⁷, Daniel J. DeAngelo, MD, PhD^8*, Harry P. Erba⁹, Anjali Advani, MD¹⁰, Patrick W. Burke, MD¹¹, Giovanni Martinelli, MD¹², Lauris Gastaud, MD^13*, Xavier Thomas, MD, PhD¹⁴, Jessica K. Altman, MD¹⁵, Lourdes M. Mendez, MD, PhD¹⁶, Adolfo de la Fuente, MD^17*, Elisabetta Todisco, MD, PhD^18*, Gianluca Gaidano, MD¹⁹, Antonio Curti, MD, PhD²⁰, Nicolas Boissel, MD, PhD²¹, Christian Recher, MD²², Christoph Schliemann, Prof., MD^23*, Marina Konopleva, MD, PhD¹, David A. Sallman, MD²⁴, Laura Torres, MD^25*, Guido Marcucci, MD²⁶, Hagop Kantarjian, MD²⁷, Callum M Sloss, PhD²⁸, Kara E Malcolm, RN^28*, Patrick A Zweidler-McKay, MD, PhD²⁸ and Kendra Sweet, MD²⁴

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA
³Hospital Universitari i Politècnic La Fe, Valencia, Spain
⁴Division of Hematology & Medical Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
⁵Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁶Fred Hutchinson Cancer Research Center, Seattle, WA
⁷University of California Irvine, Chao Family Comprehensive Cancer Center, Orange, CA
⁸Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
⁹Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC
¹⁰Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
¹¹Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
¹²Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology “L. e A. Seràgnoli”, Bologna, Italy
¹³Medical Oncology Department, Antoine Lacassagne Hospital, Nice, France
¹⁴Department of Hematology, Hospices Civils de Lyon, Lyon-Sud Hospital, Lyon, France
¹⁵Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL
¹⁶Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
¹⁷MD Anderson Cancer Center Madrid, Madrid, Spain
¹⁸Division of Onco-Hematology, European Institute of Oncology IRCCS, Milano, Italy
¹⁹Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
²⁰IRCCS Azienda ospedaliero-universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
²¹Université de Paris, Service Hématologie, Hôspital Saint-Louis, Paris, France
²²Service d'Hématologie, CHU de Toulouse - Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
²³Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
²⁴Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²⁵Hematology Department, Hospital Universitario La Fe de Valencia, Valencia, Spain
²⁶Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
²⁷The University of Texas MD Anderson Cancer Center, Houston, TX
²⁸ImmunoGen, Waltham, MA